| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |